Global Medical REIT/$GMRE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Global Medical REIT
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
Ticker
$GMRE
Sector
Primary listing
NYSE
Industry
Health Care REITs
Headquarters
Employees
26
ISIN
US37954A2042
Website
GMRE Metrics
BasicAdvanced
$451M
206.62
$0.03
1.27
$0.84
8.90%
Price and volume
Market cap
$451M
Beta
1.27
52-week high
$9.15
52-week low
$6.06
Average daily volume
727K
Dividend rate
$0.84
Financial strength
Current ratio
1.369
Quick ratio
1.239
Long term debt to equity
125.818
Total debt to equity
127.907
Dividend payout ratio (TTM)
831.08%
Interest coverage (TTM)
1.15%
Profitability
EBITDA (TTM)
84.793
Gross margin (TTM)
99.89%
Net profit margin (TTM)
5.80%
Operating margin (TTM)
24.07%
Revenue per employee (TTM)
$5,320,000
Management effectiveness
Return on assets (TTM)
1.64%
Return on equity (TTM)
1.43%
Valuation
Price to earnings (TTM)
206.622
Price to revenue (TTM)
3.231
Price to book
1.02
Price to tangible book (TTM)
1.13
Price to free cash flow (TTM)
7.18
Free cash flow yield (TTM)
13.93%
Free cash flow per share (TTM)
93.88%
Dividend yield (TTM)
12.46%
Forward dividend yield
8.90%
Growth
Revenue change (TTM)
-1.23%
Earnings per share change (TTM)
-85.66%
3-year revenue growth (CAGR)
4.69%
10-year revenue growth (CAGR)
50.99%
3-year earnings per share growth (CAGR)
-45.63%
10-year earnings per share growth (CAGR)
-39.00%
3-year dividend per share growth (CAGR)
0.60%
10-year dividend per share growth (CAGR)
-4.11%
Bulls say / Bears say
Global Medical REIT's strategic acquisitions, including a 15-property portfolio for $80.3 million, have expanded its leasable area and increased annualized base rent, enhancing revenue potential. (tradingview.com)
Analysts have initiated coverage with a 'neutral' rating and a $9.00 price target, suggesting potential upside from the current trading price. (marketbeat.com)
The company's underwriting practices have been effective, ensuring stable forward cash flows despite market concerns over tenant bankruptcies. (seekingalpha.com)
Global Medical REIT faces refinancing challenges due to low average debt maturity, which could lead to higher interest costs and weigh on AFFO growth in the coming years. (seekingalpha.com)
The company reported a net loss attributable to common stockholders of $3.1 million in Q2 2024, primarily due to a loss on the sale of an investment property, indicating potential volatility in financial performance. (tradingview.com)
Despite strategic acquisitions, rental revenue decreased by 5.8% year-over-year in Q2 2024, reflecting the impact of property dispositions and rent reserves, which may affect short-term revenue stability. (tradingview.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
GMRE News
AllArticlesVideos
Global Medical REIT Appoints Mark Decker, Jr. as CEO
Business Wire·5 days ago
Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends
Business Wire·4 weeks ago
Global Medical REIT Inc. Announces Dates for 2025 First Quarter Earnings Release and Webcast
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Global Medical REIT stock?
Global Medical REIT (GMRE) has a market cap of $451M as of June 28, 2025.
What is the P/E ratio for Global Medical REIT stock?
The price to earnings (P/E) ratio for Global Medical REIT (GMRE) stock is 206.62 as of June 28, 2025.
Does Global Medical REIT stock pay dividends?
Yes, the Global Medical REIT (GMRE) stock pays dividends to shareholders. As of June 28, 2025, the dividend rate is $0.84 and the yield is 8.9%. Global Medical REIT has a payout ratio of 831.08% on a trailing twelve-month basis.
When is the next Global Medical REIT dividend payment date?
The next Global Medical REIT (GMRE) dividend payment date is unconfirmed.
What is the beta indicator for Global Medical REIT?
Global Medical REIT (GMRE) has a beta rating of 1.27. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.